(Q45353103)

13 December 2017

title

Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach (English)

1 reference

13 December 2017

1 reference

V Karthick

1

1 reference

13 December 2017

K Ramanathan

series ordinal

2

1 reference

13 December 2017

V Shanthi

series ordinal

3

1 reference

13 December 2017

R Rajasekaran

series ordinal

4

1 reference

13 December 2017

publication date

1 July 2013

1 reference

Cell Biochemistry and Biophysics

13 December 2017

published in

1 reference

13 December 2017

volume

66

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

657-669

1 reference

Origin of highly pathogenic H5N1 avian influenza virus in China and genetic characterization of donor and recipient viruses

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Analysis of a point mutation in H5N1 avian influenza virus hemagglutinin in relation to virus entry into live mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Resistance of influenza viruses to neuraminidase inhibitors--a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Avian flu: isolation of drug-resistant H5N1 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Oseltamivir resistance during treatment of influenza A (H5N1) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Oseltamivir resistance--disabling our influenza defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Relationships between membrane binding, affinity and cell internalization efficacy of a cell-penetrating peptide: penetratin as a case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

The threat of an avian influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Vaccines and antiviral drugs in pandemic preparedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Integrating virtual screening in lead discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Docking and scoring in virtual screening for drug discovery: methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Testing a flexible-receptor docking algorithm in a model binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

An improved relaxed complex scheme for receptor flexibility in computer-aided drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Small molecule inhibitors of the MDM2-p53 interaction discovered by ensemble-based receptor models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

PubChem: Integrated Platform of Small Molecules and Biological Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

A complete small molecule dataset from the protein data bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Exploiting PubChem for Virtual Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Automatic generation of 3D-atomic coordinates for organic molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

GROMACS: fast, flexible, and free

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Virtual screening of chemical libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

PatchDock and SymmDock: servers for rigid and symmetric docking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Solvent-accessible surfaces of proteins and nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Analytical molecular surface calculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Determination of atomic desolvation energies from the structures of crystallized proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Selection criteria for drug-like compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Property distribution of drug-related chemical databases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Conformational change of proteins arising from normal mode calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

ElNemo: a normal mode web server for protein movement analysis and the generation of templates for molecular replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

On the potential of normal-mode analysis for solving difficult molecular-replacement problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

A New Atom-Additive Method for Calculating Partition Coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

On the use of low-frequency normal modes to enforce collective movements in refining macromolecular structural models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Normal modes for predicting protein motions: a comprehensive database assessment and associated Web tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Improving thermostability of papain through structure-based protein engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Representing receptor flexibility in ligand docking through relevant normal modes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

GROMACS 3.0: a package for molecular simulation and trajectory analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

Computing chemistry on the web

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-012-9510-7

10.1007/S12013-012-9510-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1005101598

0 references

1 reference